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ABSTRACT  
Objective: The aim of this study was to enhance the dissolution rate of hydrochlorothiazide (HCTZ).  
Methods: Binary solid dispersions (SDs) of HCTZ with increasing weight ratios of poloxamer 407, polyethylene glycol 6000 (PEG 6000) or gelucire 
50/13 were prepared by solvent evaporation technique. The solid dispersions were deposited on the surface of aerosil 200 to produce a dry 
product with large surface area. The SDs were characterized with respect to drug dissolution. The mechanism of dissolution enhancement was 
researched using Fourier transform infrared spectroscopy (FTIR) and differential scanning calorimetry (DSC). 
Results: The unprocessed drug showed erratic, slow dissolution which can be explained on the basis of its hydrophobic nature. Preparation of SDs 
with hydrophilic carriers resulted in a significant increase in the dissolution rate with most of the drug being liberated in the first 5 min. The 
dissolution pattern of the drug from the prepared SDs depends mainly on the type of polymer used, and the best dissolution pattern was observed 
in the SD prepared using 1:1 ratio of the drug to gelucire 50/13 in the presence of aerosil 200 as a carrier. FTIR studies revealed no interaction 
between the drug and polymers. DSC showed a change in the crystalline structure of the drug after SDs formation. This change can explain the 
recorded dissolution enhancement.  
Conclusion: The study presented a system capable of increasing the dissolution rate of HCTZ using polymers which can increase the intestinal 
permeability as well.  
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INTRODUCTION 
Hydrochlorothiazide (HCTZ) belongs to an important group of drugs 
benzothiadiazine thiazide diuretics [1]. It is used alone or in 
combination with other therapeutic agents in the treatment of 
hypertension [2]. It is also indicated in the management of edema 
resulting from mild-to-moderate congestive heart failure or from 
chronic hepatic or renal disease [3-4]. The drug is categorized in 
class IV according to the Biopharmaceutical Classification System 
(BCS). This classification is based on the poor solubility of HCTZ 
which is associated with poor membrane permeability. It is thus 
characterized by poor and variable bioavailability which is believed 
to be due to poor solubility and slow dissolution with a contribution 
from the poor membrane permeability [5-6]. Its peak plasma 
concentration (t max) was recorded within 1 to 5 h of dosing, and 
ranged from 70 to 490 ng/ml, depending on the dose. The variability 
in the t  max
Alternative techniques have been adopted to enhance the 
dissolution rate of HCTZ. These included preparation of spheres 
based on starch, microcrystalline cellulose or crospovidone [7-9]. 
Other techniques included micellar solubilization, inclusion 
complexation, and development of liquisolid systems [10-12]. Other 
investigators utilized the solid dispersion (SD) technique which was 
prepared by fusion, solvent evaporation or spray drying [13-14]. 
The benefits of the dissolution enhancement can be even greater if 
the selected excipient was able to enhance the membrane 
permeability of drugs. Such excipient will be efficient with class IV 
drugs as it will serve a dual function by improving the dissolution 
rate and membrane permeability. Accordingly the objective of this 
work was to enhance the dissolution rate of HCTZ by the 
formulation of SDs with polymers having the potential to enhance 
the membrane permeability.  
 can be attributed to the same factors contributing to poor 
bioavailability. 
MATERIALS AND METHODS 
Materials 
Hydrochlorothiazide, poloxamer 407 and aerosil 200 were obtained 
as gift samples from Sigma Pharmaceutical Company, Quwessna, 
Egypt. Gelucire 50/13 was kindly provided by Gattefosseé, France. 
Polyethylene glycol 6000 (PEG 6000) was purchased from El Nasr 
Pharmaceutical Chemicals Co, Egypt. All other chemicals and 
reagents were of analytical grade. 
Assay of hydrochlorothiazide  
The in vitro dissolution studies employed spectroscopic 
determination of the drug which was measured at 272 nm using a 
spectrophotometer (Thermo, Evo300pc, USA) [15]. 
 
Table 1: Composition of the tested formulations 
Formulation code Drug Poloxamer 407 PEG 6000 Gelucire 50/13 Aerosil 200 
X111 1 1 - - 1 
X122 1 2 - - 2 
X134 1 4 - - 3 
E111 1 - 1 - 1 
E122 1 - 2 - 2 
E134 1 - 4 - 3 
G111 1 - - 1 1 
G122 1 - - 2 2 
G134 1 - - 4 3 
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Preparation of solid dispersions  
Binary and ternary SDs of the drug with various polymers were 
prepared by solvent evaporation according to the composition 
presented in table 1[16]. The drug and the polymer(s) were 
dissolved in a mixture of methylene chloride with ethanol and 
acetone (1:1:1). The organic solvent was removed by evaporation 
over a water bath at 50 oC with continuous stirring until complete 
evaporation. Solid dispersions of the drug with poloxamer 407, PEG 
6000 and gelucire 50/13 were of low melting points. Accordingly, 
aerosil 200 was added to these systems to produce a dry powder 
with large surface area. The resulting SDs were passed through 0.8 
mm Sieve. 
Fourier transforms infrared spectroscopy 
The Fourier transform infrared (FTIR) was used to investigate any 
interaction between the drug and polymers. FTIR spectra of HCTZ, 
Poloxamer 407, PEG 6000, gelucire 50/13 and their SDs were 
recorded using FTIR spectrophotometer (Bruker Tensor 27, 
Germany) which was used in potassium bromide diffuse reflectance 
mode for collecting the IR spectra of the samples. The system is 
equipped with a DLaTGS detector. Samples were mixed with 
potassium bromide (spectroscopic grade) and were compressed into 
disks using hydraulic press before scanning from 4000 to 400 cm-1. 
Data analysis was performed using Opus IR, FTIR spectroscopy 
Software. 
Differential scanning calorimetry 
Differential scanning calorimetry (DSC) was used to characterize the 
SDs. This employed differential scanning calorimeter equipment 
(Differential scanning calorimeter DSC6, Perkin Elmer, USA). Samples 
of the drug, the polymers and their SDs were loaded into aluminum 
pans and the lids were crimped using Perkin Elmer crimper. The 
thermal behavior of each sample was investigated under nitrogen at a 
heating rate of 10 oC/min, covering temperature ranges of 30–300 o
The dissolution pattern of the drug was monitored for the drug from 
its unprocessed powder and from the binary and ternary SDs with 
various hydrophilic polymers. This employed USP type II dissolution 
apparatus (Copley, NG 42JY, Nottingham, UK). The dissolution 
medium was 900 ml of 0.1 N HCl (pH 1.2) which was maintained at a 
temperature of 37
C. 
The instrument was calibrated with an indium standard. Data analysis 
was conducted using Pyris thermal analysis software.  
Determination of the drug dissolution 
o
RESULTS AND DISCUSSION 
C with a paddle speed being adjusted to 100 rpm. 
Powdered samples equivalent to 50 mg HCTZ were added to the 
dissolution vessels while stirring. Samples (5 ml) were taken at 0, 5, 
10, 15, 30, 45 and 60 min. These samples were immediately filtered 
through 0.45 μm filters, discarding the first 2 ml of the filtrate before 
determination of the drug concentration by spectrophotometry at 
272 nm. The withdrawn volume was replaced with dissolution 
medium at each time interval to maintain a constant volume of 
dissolution medium. The dissolution profile of the dissolved HCTZ 
was constructed by plotting the cumulative amount of drug 
dissolved (expressed as % of the total amount of HCTZ added) as a 
function of time. The amount of drug dissolved in the first 5 and 10 
min (Q5 and Q10) was calculated. The dissolution efficiency (DE) 
was obtained from the area under the curve of the dissolution 
profile using the nonlinear trapezoidal rule and demonstrated as a 
percentage of the area of the rectangle described by 100 % 
dissolution in the same time [17]. 
Solid state characterization of the binary and ternary systems 
Solid state characterization of binary and ternary SDs employed 
FTIR and DSC. This was conducted in an attempt to explain the 
mechanism of enhanced dissolution (if any) after SDs formation. 
FTIR dispersions studies  
Fig. 1 shows the FTIR spectra of HCTZ and its SDs with various 
polymers. The FTIR spectrum of pure HCTZ reveals the 
characteristic peaks which included those corresponding to NH-
stretching, which was recorded at 3362, 3267 and 3169 cm-1. The 
spectrum also revealed the characteristic peaks for the SO2. The 
characteristic peaks for the SO2 group were detected at 1319 cm-1 
for SO2 asymmetric stretching vibrations and at 1166 and 1059 cm-1 
for the SO2 symmetric stretching vibrations. The CH-stretching was 
recorded as a band at 3098 cm-1, CH2 stretching was noticed at 2947 
and 2836 cm-1 with the C=C stretching vibrations being recorded at 
1605 and 1521 cm-1. This spectrum is in good agreement with the 
published data on the same drug [6].  
The FTIR spectrum of poloxamer 407 (fig. 1a) showed characteristic 
peaks at 2972, 2887 cm-1 for C–H stretch, at 1469 cm-1 for C–H 
bending vibrations, and at 1345, 1242, 1282, 1148, 1112, and 1061 
cm-1 for the C-O stretching vibration. This correlates well with the 
published spectrum of the surfactant [18]. 
In the case of PEG 6000, the spectrum (fig. 1b) was characterized by 
the appearance of a broadband at 3421 cm-1 which corresponds to the 
OH group. The band at 1114 cm-1 is for C–O stretching and that at 2882 
cm-1 for the CH stretching vibrations. The recorded spectrum is in 
good agreement with the published work on the same polymer [19]. 
The FTIR spectrum of gelucire 50/13 (fig. 1c) reveals the 
characteristic absorption band of the OH stretching at 3444 cm-1, 
that for C–H stretching at 2920 cm-1, that C=O stretching at 1737 cm-
1, and the C–O stretching at 1110 cm-1
The FTIR spectrum of aerosil 200 (fig. 1) revealed an absorption 
band at 3448 cm
 [20]. 
-1 which can be attributed to hydroxyl group which 
results from intermolecular hydrogen bonding between the water of 
crystallization and silica oxygen or formation of chelate compounds. 
The peak of H–O–H bending of water of crystallization was recorded 
at 1632 cm-1. The Si–O symmetric stretching vibration of silica was 
observed at 1110 cm-1 with the bands corresponding to the 
asymmetric Si–O stretching and Si–O bending modes of silica being 
recorded at around 808 cm-1 and 475 cm-1. This spectrum is similar 





Fig. 1: FTIR of binary SDs of HCTZ using (a) poloxamer 407, (b) PEG 6000 or (c) gelucire 50/13 in the presence of aerosil 200 (formulation 
details are presented in table: 1) 
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The FTIR spectrum of the SD of the drug with poloxamer 407 revealed 
the characteristic peaks of the drug which were recorded in positions 
similar to those of pure drug (fig. 1a). This indicates the absence of 
interaction between the drug and the polymer. With respect to the 
FTIR spectrum of the drug in the SD with either PEG 6000 or gelucire 
50/13 in the presence of aerosil 200, there were some changes in the 
spectrum relative to that of pure drug (fig. 1b, fig. 1c). These changes 
were in the form broadening of the peaks corresponding to the NH 
group. This can be taken as a sign of hydrogen bonding between the 
drug and the polymer. A Similar conclusion was previously reported 
based on similar changes in the FTIR spectra of other drugs after 
incorporation in the SD with the same polymer [22, 23]. 
Differential scanning calorimetry 
Fig. (2-4) show examples of the DSC traces of HCTZ and its SDs with 
poloxamer 407, PEG 6000 or gelucire 50/13 in the presence of 
aerosil 200 as a carrier. The calculated thermodynamic parameters 
are presented in table 2.  
The pure drug produced a characteristic sharp endothermic peak 
with a Tm of 269 oC (fig. 2). This reflects the crystalline nature of the 
unprocessed drug. A similar thermogram was recorded for the same 
drug by other investigators [6]. With respect to aerosil 200, the DSC 
pattern was free from any endothermic or exothermic peak (fig. 2). 
This thermal behavior can be taken as a reflection of the amorphous 
nature of this material. A Similar finding was recorded in literature 
and was explained similarly. This explanation is supported by the 
published X-ray diffraction pattern for the same material [6]. The 
thermogram of pure poloxamer 407 showed a very sharp 
endothermic peak at 57.5 oC (fig. 2). This peak corresponds to the 
melting transition of the polymer. The melting transition of 
poloxamer is in good agreement with the published work on the 
polymer [18]. Pure PEG 6000, the thermogram revealed a sharp 
endothermic peak at 63.4 oC (fig. 3). This endotherm corresponds to 
the melting point of PEG 6000 and agrees with the published data 
[24]. The thermogram of pure gelucire 50/13 showed a very sharp 
endothermic peak at 45.2 o
Formulation of HCTZ as a binary SD with poloxamer 407 in the 
presence of aerosil 200 as a carrier resulted in the broadness of the 
endothermic peak of the drug with a significant reduction in the Tm 
of the transition. This reduction depended on the proportion of 
poloxamer, increasing poloxamer concentration in the SD, reducing 
the Tm of the drug. The reduction in the Tm was associated with the 
reduction in the enthalpy of the transition (fig. 2, table: 2). This 
pattern can be explained on the basis of the possible partial 
transformation of the drug to an amorphous structure. Another 
possible explanation can depend on possible eutectic mixture 
formation. A Similar effect was reported for poloxamer 407 when 
formulated with glibenclamide and was similarly explained [18]. 
C corresponding to the melting point of 
the polymer (fig. 4). The melting transition of gelucire 50/13 is in 
good agreement with the recorded data for the polymer [23].  
Formulation of HCTZ as an SD with PEG 6000 in the presence of aerosil 
200 resulted in the broadness of the endothermic peak of the drug with 
the Tm being shifted to the lower value in case of 1:1 weight ratio (drug 
to polymer). This was associated with a reduction in the enthalpy for the 
transition. Increasing the proportion of PEG 6000 resulted in a 
thermogram with the Tm of the drug nearly disappeared (fig. 3, table: 2). 
This effect can be due to the transformation of the drug to the 
amorphous structure or eutectic mixture formation. The same trend was 







Fig. 2: DSC traces of HCTZ and its SDs with poloxamer 407 in the presence of aerosil 200 
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Preparation of SD of the drug with gelucire 50/13 in the presence of 
aerosil 200 resulted in a reduction in the Tm and intensity of the 
endothermic peak of the drug compared with the unprocessed drug. 
The reduction in the peak intensity was manifested as a decrease in 
the enthalpy of the transition with the effect increasing as the 
proportions of the surfactant increased (fig. 4, table: 2). This 
suggests the partial transformation of drug crystals into an 
amorphous structure or possible solubility in the carrier. The 
possibility of mixture eutectic formation was suggested for similar 
effects with other drugs [20, 23]. 
It is important to emphasize that SD formation of HCTZ affected the 
melting transition of the polymers as well. This was manifested as 
the broadening of the melting transition of poloxamer 407, PEG 
6000 and gelucire 50/13 (fig. 2, 3 and 4). Broadening of the 
transition endotherm is due to the reduction in the cooperativity of 
the transition. This highlights the physical interaction between the 
drug and the polymer and confirms the recorded changes in the 
melting transition of the drug. A similar finding has been recorded 
by other investigators for SDs of other drugs and was similarly 
explained [20]. 
Dissolution studies  
The dissolution profiles of pure HCTZ and the prepared SD 
formulations are shown in fig. 5. The calculated dissolution 
parameters are presented in table 2. The dissolution profiles of 
HCTZ in a pure state revealed poor and slow dissolution with only 
29.74 and 37.06 % of the drug being liberated in the first 5 and 10 
min respectively. The dissolution efficiency (DE) was calculated to 
be 55.9 %. This poor and slow dissolution rate of the drug can be 
attributed to its hydrophobic nature. Similar dissolution pattern was 
recorded by other investigators [6]. 
Preparation of binary SDs of the drug with poloxamer 407 resulted 
in an increase in the dissolution rate of the drug. For 1:1 drug to 
polymer ratio the Q5, Q10, and DE were significantly increased to be 
73.96, 80.62 and 77.4 % respectively. Further increase in the 
polymer ratio to 2 and 4 resulted in an additional increase in the 
dissolution rate of the drug (fig. 5a, table: 2). Different possible 
explanations for enhancing the dissolution rate of the drug after SD 
formation with poloxamer 407 were previously reported. The first 
possible one is the wetting effect of the polymer which resulted in an 
improvement in the wetting characteristics of the drug. This was 
revealed from the rapid dispersion of the dry SD formulation in the 
dissolution medium compared to the pure, unprocessed drug which 
tends to float [26]. The second possible explanation for the 
dissolution rate enhancement after the formation of SD with 
poloxamer 407 is the alteration in the crystalline structure of the 
drug which was clear from the results of thermal analysis. Micellar 
solubilization is another possible mechanism for enhancing the 
dissolution rate [27, 28]. Solid dispersions formation for poorly 
water soluble drugs with poloxamer 407 was successfully reported 







Fig. 3: DSC Profiles of HCTZ and its SDs using PEG 6000 in the presence of aerosil 200 
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Fig. 4: DSC Profiles of HCTZ and its SDs using gelucire 50/13 in the presence of aerosil 200Table 2: The melting transition parameters and 
the dissolution efficiency of HCTZ and its binary SDs 
 
Formulationcode Tm (Po PC) Enthalpy(ΔH) J/g DE %P* Q5 %P* Q10 %P* 
Pure drug(HCTZ) 269.3 86.740 55.9 (0.53) 29.74 (0.58) 37.06 (0.92) 
X111 258.14 11.09 77.4 (0.73) 73.96 (0.40) 80.62 (0.46) 
X122 244.7 2.8 82.73 (0.87) 82.18 (1.3) 84.07(0.57) 
E111 250.4 4.19 74.90 (0.57) 57.93 (1.25) 72.79 (1.68) 
E122 No No 81.33 (0.33) 79.64 (1.14) 81.14 (1.55) 
G111 265.2 20.2 87.99 (0.24) 83.56 (0.63) 86.38 (1.10) 
G122 261.08 9.9 84.66 (0.83) 74.38 (0.98) 86.29 (1.71) 
*n = 3, data represent mean of three observations, Values between brackets are SD (n = 3), DE= dissolution efficiency, Q5= amount of the drug 
dissolved at first 5 min, Q10= amount of the drug dissolved at first 10 min, Formulation details are presented in table: 1 
 
Fig. (5b) shows the dissolution profiles for SDs prepared using PEG 
6000 with HCTZ in the presence of aerosil 200. These dissolution 
profiles revealed the enhanced dissolution rate of the prepared 
formulations compared to the unprocessed drug. This enhancement 
was also reflected in the calculated dissolution parameters which 
were significantly increased in the case of SDs containing the drug 
with PEG 6000 at weight ratios of 1:1, 1:2 (table: 2). Further 
increase in the polymer ratio to 4 did not result in significant change 
in the drug release pattern (fig. 5b). The amount of the drug 
dissolved from SD formulation that was prepared at 1:4 drug to 
polymer weight ratio in the first 5 and 10 min (Q5 and Q10) was 
75.66 % and 82.00 %. The calculated dissolution efficiency was 
79.82 %.  
The dissolution enhancement after SDs formation with PEG 6000 
can be attributed mainly to the possible formation of the amorphous 
structure of the drug or eutectic mixture formation. This finding is in 
a good agreement with the results of thermal analysis. A similar 
explanation was reported for PEG 6000 induced dissolution 
enhancement of other poorly water soluble drugs [22, 29].  
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An improvement of wettability of the powder due to the formation 
of a film of polyethylene glycol around the drug particles which 
modifies the hydrophobicity of the surfaces is another suggested 





Fig. 5: Dissolution profiles of HCTZ as a pure drug and its binary SDs using (a) poloxamer 407, (b) PEG 6000 or (c) gelucire 50/13 in the 
presence of aerosil 200 (Error bars were omitted for clarity, formulation details are presented in table: 1) *n=3 
 
The dissolution profiles of the SDs prepared using gelucire 50/13 in 
the presence of aerosil 200 are presented in fig. 5c. With the 
calculated dissolution parameters presented in table 2, the 
dissolution profiles showed enhanced dissolution rate of the drug 
from the binary SD formulations compared to the unprocessed drug 
with the enhancement being slightly decreased upon increasing the 
concentration of gelucire 50/13. This decrease in the dissolution 
rate was reflected in the calculated dissolution efficiency which was 
decreased from 87.99 % to 84.66 % and 82.63 % in the case of SDs 
containing the drug with gelucire 50/13 at weight ratios of 1:1, 1:2 
and 1:4, respectively (table: 2).  
The rapid dissolution obtained in the case of the dispersion 
prepared using gelucire 50/13 can be attributed to micellar 
solubilization and the self-emulsifying property of gelucire 50/13 
[23, 31, 32]. The slight decrease in the drug release at higher 
polymer ratios may be due leaching out of the carrier during 
dissolution forming a concentrated layer of the solution around the 
drug particles slowing down the migration of the released drug 
particles to the bulk of the dissolution [31]. 
CONCLUSION  
Formation of a binary SD of HCTZ with different polymers in the 
presence of aerosil 200 resulted in significant enhancement in the 
dissolution rate of the drug. This enhancement may be attributed to 
change in the crystalline structure of the drug after SD formation 
and the wetting effect or the micellar solubilization and the self-
emulsifying property of the polymer.  
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